[Hypertension, CKD and bone metabolism].

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Hypertension and Chronic Kidney Disease (CKD) are frequently comorbid with osteoporosis.
• Mechanisms linking these conditions to bone loss are multifactorial, involving mineral imbalances and hormonal dysregulation.

Purpose of the Study:

• To elucidate the specific pathways through which hypertension and CKD contribute to osteoporosis.
• To investigate the role of the renin-angiotensin system in hypertension-associated bone loss.

Main Methods:

• Review of existing literature on hypertension, CKD, and osteoporosis.
• Analysis of the effects of Angiotensin II on osteoblast and osteoclast activity.
• Examination of the impact of phosphorus and FGF23 in CKD-related bone disease.

Main Results:

• Hypertension can lead to increased urinary calcium and secondary hyperparathyroidism, promoting bone resorption.
• The renin-angiotensin system, specifically Angiotensin II, upregulates RANKL, activating osteoclasts.
• CKD-induced hyperphosphatemia and altered vitamin D metabolism contribute to osteoporosis progression.

Conclusions:

• Both hypertension and CKD are significant risk factors and contributing factors to the development of osteoporosis.
• Targeting the renin-angiotensin system and managing mineral imbalances may be crucial for preventing bone loss in these patient populations.